Summary
- Current Price
- As of today, EVMN price is $15.05, down -40.23% on
- Current Price All-Time High
- EVMN price is currently -54.67% below its historical high of $33.20 set on
- Market Cap
- EVMN current market cap is $542M, with unknown 1-year change
- PE Ratio
- EVMN PE ratio is unknown
- Revenue
- EVMN current annual revenue is $13.00M, up +85.71% year-over-year
- Next Earnings
- The next earnings release for EVMN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Evommune, Inc. |
| Ticker | NYSE: EVMN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evommune.com |
| Employees | 48 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.05 | |
| Price, 1D Change | -40.23% | |
| $542M | ||
| - | ||
| - | ||
| 0.78 | ||
| $13M | ||
| Revenue, 1Y Change | +85.71% | |
| -$2.18 | ||
| EPS, 1Y Change | +3.80% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.18 | ||
| EPS Estimate | N/A | -$2.76 |
| EPS Est. Change | N/A | -26.13% |
| $13.00M | ||
| Revenue Estimate | N/A | $6.63M |
| Revenue Est. Change | N/A | -49.04% |
| Current Price | $15.05 | |
| Price Target | - | $52.00 |
| Price Tgt. Change | - | +245.51% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.27 | - | |
| -$6.40 | -$2.18 | +65.88% | |
| -$2.76 | N/A | -26.13% | |
| -$3.21 | N/A | -46.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $7.00M | - | |
| $14.43M | $13.00M | -9.90% | |
| $6.63M | N/A | -49.04% | |
| $1.77M | N/A | -86.39% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.05 | |
| $22.00 | ||
| $22.86 | ||
| - | ||
| $22.37 | ||
| -$0.29 | ||
| 0.78 | ||
| $2.21 | ||
| 31.90 | ||
| 223.02% | ||
| 135.33% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $13.00M | ||
| -$2.18 | ||
| $11.61M | ||
| 89.32% | ||
| -$81.07M | ||
| -623.62% | ||
| -$68.87M | ||
| -529.77% | ||
| -$79.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 8.57 | ||
| 8.57 | ||
| - | ||
| - | ||
| 15.00 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 54.21 | ||
| 1.78 | ||
| -3.83 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $205.57M | ||
| $149.20M | ||
| $224.95M | ||
| $153.48M | ||
| $19.38M | ||
| $17.91M | ||
| $2.06M | ||
| $589.00K | ||
| $7.76M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $81.87M | ||
| $92.68M | ||
| $1.39M | ||
| $0.00 | ||
| $1.39M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$76.44M | ||
| -$115.31M | ||
| $220.76M | ||
| $235.00K | ||
| -$76.68M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Clear Street | ||
| HC Wainwright & Co. | → | |
| Oppenheimer | ||
| Raymond James | ||
| HC Wainwright & Co. | ||
| William Blair |
Analyst sentiment
Institutional ownership
Screeners with EVMN
FAQ
What is the ticker symbol for Evommune, Inc.?
The ticker symbol for Evommune, Inc. is NYSE:EVMN
Does Evommune, Inc. pay dividends?
No, Evommune, Inc. does not pay dividends
What sector is Evommune, Inc. in?
Evommune, Inc. is in the Healthcare sector
What industry is Evommune, Inc. in?
Evommune, Inc. is in the Biotechnology industry
What country is Evommune, Inc. based in?
Evommune, Inc. is headquartered in United States
When did Evommune, Inc. go public?
Evommune, Inc. initial public offering (IPO) was on November 6, 2025
Is Evommune, Inc. in the S&P 500?
No, Evommune, Inc. is not included in the S&P 500 index
Is Evommune, Inc. in the NASDAQ 100?
No, Evommune, Inc. is not included in the NASDAQ 100 index
Is Evommune, Inc. in the Dow Jones?
No, Evommune, Inc. is not included in the Dow Jones index
When was Evommune, Inc. last earnings report?
Evommune, Inc.'s most recent earnings report was on March 26, 2026
When does Evommune, Inc. report earnings?
The next expected earnings date for Evommune, Inc. is August 6, 2026
Data Sources & References
- EVMN Official Website www.evommune.com
- EVMN Profile on Yahoo Finance finance.yahoo.com/quote/EVMN
- EVMN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evmn